Skip to content
Menu

CytoMed Therapeutics Limited GDTC

Full chart Compare
Set alert

Price alert · GDTC

All alert types
0.77 USD -0.06 (-6.87%)

Regular-session close

0.77 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

0.73 Day range 0.8499
0.68 52-week range 2.12
YTD
-42.31%
1 year
-57.29%

Revenue & Expenses

Revenue Profit Costs
Other Operating Income$384.93KGross Profit$324.39KNet Loss$3.98MExpenses$4.69MSelling, General & Admin$930.56KResearch & Development$2.22MInterest Expense$20.91KOther Expenses$1.52MRevenue$324.39K

Latest period ending Dec 31, 2025 · select a line to chart its full history

GDTC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
324.39K69.50K000
324.39K69.50K000
-2.44M-1.81M-1.34M-1.36M-1.20M
-3.98M-2.52M-4.13M-3.13M-2.05M
-0.34-0.22-0.39-0.40-0.30
GDTC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.10M4.97M9.00M1.58M2.51M
7.98M10.07M12.37M5.23M6.08M
1.13M1.02M1.12M4.64M3.49M
482.56K463.25K448.02K4.22M3.26M
6.54M8.97M11.25M586.98K2.59M
GDTC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-3.70M-2.71M-3.53M-1.40M-1.72M
929.28K1.13M-2.73M-473.31K-823.67K
208.65K-64.89K10.92M968.72K4.17M
-637.85K-1.40M-58.30K-473.31K-582.35K
-2.56M-1.65M4.66M-903.00K1.64M